Finance

Lists
Why is 2496 down 22.86%?
Dive Deeper
2496:HKG
Wuhan YZY Biopharma Co Ltd
HK$2.70
-22.86%
(-0.80) 1D
Oct 13, 9:20:09 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2496...
Mkt. cap
562.16M
Avg. vol.
53.00
Volume
0.00
52-wk high
HK$8.40
52-wk low
HK$2.20
EPS
-HK$0.19
Shares outstanding
179.48M
No. of employees
68
Mkt. cap
562.16M
Avg. vol.
53.00
Volume
0.00
52-wk high
HK$8.40
52-wk low
HK$2.20
EPS
-HK$0.19
Shares outstanding
179.48M
No. of employees
68
News stories
From web sources and news partners
About Wuhan YZY Biopharma Co Ltd
CEO-
Employees68
Founded2010
Headquarters-
SectorBiotechnology
Websiteyzybio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.24M
11.24M
17.89M
17.89M
Cost of goods sold
13.30M
13.30M
3.94M
3.94M
Cost of revenue
13.30M
13.30M
3.94M
3.94M
Research and development expenses
9.01M
9.01M
8.79M
8.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.36M
5.36M
6.70M
6.70M
Operating expense
9.51M
9.51M
15.50M
15.50M
Total operating expenses
22.81M
22.81M
19.44M
19.44M
Operating income
-11.57M
-11.57M
-1.55M
-1.55M
Other non operating income
-15.50K
-15.50K
-101.50K
-101.50K
EBT including unusual items
-12.95M
-12.95M
-3.13M
-3.13M
EBT excluding unusual items
-12.95M
-12.95M
-3.09M
-3.09M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-4.85M
-4.85M
-
-
Net income
-12.95M
-12.95M
-3.13M
-3.13M
Net profit margin
-115.16%
-115.16%
-17.50%
-17.50%
Earnings per share
-
-
-
-
Interest and investment income
128.50K
128.50K
127.50K
127.50K
Interest expense
-1.28M
-1.28M
-1.04M
-1.04M
Net interest expenses
-1.16M
-1.16M
-912.50K
-912.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.71M
-10.71M
-697.50K
-697.50K
Gain or loss from assets sale
7.50K
7.50K
-
-
AI content may include mistakes. Learn more
Google apps